Gynecological Oncology — Medicare Part B billing by state
21 physician groups whose primary specialty is Gynecological Oncology billed $2.6M to Medicare fee-for-service in 2023.
Calendar year 2023 · Medicare fee-for-service Part B
You're viewing calendar year 2023. State market links open the latest data year.
On this page: Billing by state · Top codes
Medicare billing by state
| State | Standardized payments | Medicare payments | Groups | Pay / group | Services | Benef.-episodes | Svc / group |
|---|---|---|---|---|---|---|---|
| New Mexico | $756K | $740K | 2 | $370K | 60,786 | 2,862 | 30,393 |
| Florida | $627K | $660K | 3 | $220K | 28,111 | 3,486 | 9,370 |
| California | $300K | $312K | 2 | $156K | 6,568 | 2,697 | 3,284 |
| Tennessee | $184K | $173K | 1 | $173K | 9,523 | 900 | 9,523 |
| Alabama | $170K | $167K | 1 | $167K | 13,160 | 10,448 | 13,160 |
| Nevada | $123K | $110K | 2 | $55K | 1,437 | 1,002 | 718 |
| North Carolina | $120K | $114K | 2 | $57K | 3,047 | 1,041 | 1,524 |
| Texas | $91K | $88K | 1 | $88K | 2,079 | 442 | 2,079 |
| New York | $90K | $110K | 3 | $37K | 624 | 524 | 208 |
| New Jersey | $70K | $75K | 1 | $75K | 774 | 682 | 774 |
| Missouri | $21K | $18K | 1 | $18K | 145 | 110 | 145 |
| Louisiana | $21K | $19K | 1 | $19K | 136 | 114 | 136 |
| Alaska | $18K | $23K | 1 | $23K | 204 | 112 | 204 |
| Washington | $13K | $17K | 1 | $17K | 144 | 81 | 144 |
Need this specialty's market in one document?
Register your interestEach group carries one specialty label — the specialty most common among its clinicians in CMS's Doctors and Clinicians register — so every figure on this page counts groups, not individual clinicians. An organization's entire Medicare billing is credited to that one label, so a specialty's totals reflect how organizations are labeled, not the specialty of each service; large multi-specialty organizations — where no single specialty is a majority of the clinicians — account for much of the volume shown under many specialties. Totals include only volume that can be credited to a single group; clinicians registered with more than one group are left out of group totals and shown as “—” elsewhere on Nevvi. Clinicians not registered with any group, and groups without a specialty label, are also not included. A group is counted in every state its clinicians bill Medicare from, so state figures overlap and never sum to the national figure.
All figures are Medicare fee-for-service Part B only; Medicare Advantage claims are not included. Cross-state comparisons use standardized payments, which remove regional differences in what Medicare pays; services without a standardized amount — mainly Part B drugs — are not in that column, and the Medicare payments column shows what Medicare actually paid. Beneficiary counts are beneficiary-episodes: one person treated in more than one setting or state is counted in each.
Top codes by Medicare payments CY2023
8 more CPT-coded procedures — shown with a trial or subscription, under AMA licensing.
| Code | Medicare payments | Services | Largest state markets |
|---|---|---|---|
| J9271 · Injection, pembrolizumab, 1 mg | $279K | 6,400 | NMFLCATNAL |
| J2506 · Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | $98K | 1,152 | NMFLCATNAL |
| Q5118 · Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | $87K | 3,770 | NMFLCATNAL |
| J7329 · Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg top by services | $20K | 2,775 | NMFLCATNAL |
| J0185 · Injection, aprepitant, 1 mg top by services | $14K | 10,790 | NMFLCATNAL |
| J9267 · Injection, paclitaxel, 1 mg top by services | $4K | 43,172 | NMFLCATNAL |
| J1453 · Injection, fosaprepitant, 1 mg top by services | $766 | 6,300 | NMFLCATNAL |
| J1100 · Injection, dexamethasone sodium phosphate, 1 mg top by services | $613 | 6,338 | NMFLCATNAL |